Neuland Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE794A01010
NSEID: NEULANDLAB
BSEID: 524558

INR

16,141.05

-89.2 (-0.55%)

BSENSE

Dec 12

BSE+NSE Vol: 43.94 k

{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16,141.05",
    "chg": -89.2,
    "chgp": "-0.55%",
    "dir": -1,
    "prev_price": "16,230.25",
    "mcapval": "20,938.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE794A01010",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "43.94 k",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-sees-technical-momentum-shift-amid-mixed-market-signals-3755873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NeulandLaborato_technicaldot_3755873.png",
        "date": "2025-12-11 08:01:29",
        "description": "Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from a bullish to a mildly bullish trend, underscoring a nuanced market assessment as the stock navigates current price pressures and broader sector dynamics."
      },
      {
        "title": "Neuland Laboratories Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-3754614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NeulandLaborato_technicaldot_3754614.png",
        "date": "2025-12-10 08:01:56",
        "description": "Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting evolving price momentum and mixed signals from key indicators such as MACD, RSI, and moving averages. This article analyses the recent market assessment changes and their implications for investors."
      },
      {
        "title": "Neuland Laboratories: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-hold-amid-mixed-financial-and-technical-signals-3752833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NeulandLaborato_mojoScore_3752833.png",
        "date": "2025-12-09 08:14:48",
        "description": "Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This nuanced shift reflects a complex interplay of recent quarterly results, long-term growth patterns, and evolving market signals."
      },
      {
        "title": "Neuland Laboratories Sees Shift in Technical Momentum Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-technical-momentum-shifts-amid-mixed-market-signals-3752657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NeulandLaborato_technicaldot_3752657.png",
        "date": "2025-12-09 08:04:06",
        "description": "Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and technical indicators. Recent trading sessions have revealed a transition from a bullish to a mildly bullish trend, accompanied by mixed signals from key technical parameters such as MACD, RSI, and moving averages."
      },
      {
        "title": "Neuland Laboratories Sees Robust Trading Activity Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-surges-on-high-value-trading-and-institutional-interest-3744307",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NeulandLaborato_most_active_equities_by_value_3744307.png",
        "date": "2025-12-03 13:00:10",
        "description": "Neuland Laboratories Ltd emerged as one of the most actively traded stocks by value on 3 December 2025, registering significant market interest within the Pharmaceuticals & Biotechnology sector. The stock demonstrated notable price movement and trading volumes, outperforming its sector peers and the broader Sensex index during the session."
      },
      {
        "title": "Neuland Labs. Sees Revision in Market Assessment Amid Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-labs-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-technical-gains-3733280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NeulandLabs_mojoScore_3733280.png",
        "date": "2025-11-27 10:05:37",
        "description": "Neuland Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment follows notable developments in the company’s operational performance and market positioning."
      },
      {
        "title": "Why is Neuland Labs. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-neuland-labs-fallingrising-3719057",
        "imagepath": "",
        "date": "2025-11-21 00:07:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Performance</strong></p>\n<p>Neuland Laboratories has experienced a consecutive four-day decline, resulting in a cumulative loss of 3.47% over this period. The stock underperformed its sector by 1.01% on the day, touching an intraday low of ₹16,651.95, which represents a 2.43% drop from previous levels. Notably, the stock’s price remains above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling underlying strength, but it has slipped below the 5-day moving average, indicating short-term selling pressure.</p>\n<p>Investor participation has also waned, with delivery volume on 19 Nov falling sharply by 57.4% compared to the five-day average. This decline in trading activity suggests reduced enthusiasm among investors, which may be contributing..."
      },
      {
        "title": "Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-hits-new-52-week-high-of-rs-197484-3685160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NeulandLaborato_priceRelatedfactors_3685160.png",
        "date": "2025-11-10 10:28:59",
        "description": "Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It has delivered impressive financial results and maintains high institutional holdings, indicating a solid market position."
      },
      {
        "title": "Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-hits-new-52-week-high-of-rs-197484-3685168",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NeulandLaborato_priceRelatedfactors_3685168.png",
        "date": "2025-11-10 10:28:51",
        "description": "Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It reported impressive financial metrics, including record operating cash flow and net sales, highlighting its growth potential and stability."
      }
    ],
    "total": 712,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "09-Dec-2025",
      "details": "Intimation of cancellation of Analyst / Institutional Investor Meeting scheduled to be held on December 10 2025",
      "source": "BSE"
    },
    {
      "caption": "Re-Lodgement Of Transfer Request Of Physical Shares",
      "datetime": "08-Dec-2025",
      "details": "Re-Lodgement of Transfer Request of Physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Dec-2025",
      "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on December 10 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Neuland Laboratories Technical Momentum Shifts Amid Mixed Market Signals

2025-12-11 08:01:29

Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from a bullish to a mildly bullish trend, underscoring a nuanced market assessment as the stock navigates current price pressures and broader sector dynamics.

Neuland Laboratories Shows Mixed Technical Signals Amid Price Momentum Shift

2025-12-10 08:01:56

Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting evolving price momentum and mixed signals from key indicators such as MACD, RSI, and moving averages. This article analyses the recent market assessment changes and their implications for investors.

Neuland Laboratories: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-09 08:14:48

Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This nuanced shift reflects a complex interplay of recent quarterly results, long-term growth patterns, and evolving market signals.

Neuland Laboratories Sees Shift in Technical Momentum Amid Mixed Market Signals

2025-12-09 08:04:06

Neuland Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and technical indicators. Recent trading sessions have revealed a transition from a bullish to a mildly bullish trend, accompanied by mixed signals from key technical parameters such as MACD, RSI, and moving averages.

Neuland Laboratories Sees Robust Trading Activity Amid Sector Outperformance

2025-12-03 13:00:10

Neuland Laboratories Ltd emerged as one of the most actively traded stocks by value on 3 December 2025, registering significant market interest within the Pharmaceuticals & Biotechnology sector. The stock demonstrated notable price movement and trading volumes, outperforming its sector peers and the broader Sensex index during the session.

Neuland Labs. Sees Revision in Market Assessment Amid Strong Financial Trends

2025-11-27 10:05:37

Neuland Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment follows notable developments in the company’s operational performance and market positioning.

Why is Neuland Labs. falling/rising?

2025-11-21 00:07:44

Short-Term Price Movement and Market Performance

Neuland Laboratories has experienced a consecutive four-day decline, resulting in a cumulative loss of 3.47% over this period. The stock underperformed its sector by 1.01% on the day, touching an intraday low of ₹16,651.95, which represents a 2.43% drop from previous levels. Notably, the stock’s price remains above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling underlying strength, but it has slipped below the 5-day moving average, indicating short-term selling pressure.

Investor participation has also waned, with delivery volume on 19 Nov falling sharply by 57.4% compared to the five-day average. This decline in trading activity suggests reduced enthusiasm among investors, which may be contributing...

Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4

2025-11-10 10:28:59

Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It has delivered impressive financial results and maintains high institutional holdings, indicating a solid market position.

Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4

2025-11-10 10:28:51

Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It reported impressive financial metrics, including record operating cash flow and net sales, highlighting its growth potential and stability.